Good news! SII in talks with Novovax to develop vaccine against monkeypox, says Adar Poonawalla
The SII CEO Adar Poonawalla has said that the SII is in talks with Novovax to develop a messenger RNA (mRNA) vaccine for monkeypox soon
Jul 26, 2022, 19:04 PM ISTNovovax Covid-19 vaccine gets emergency use nod for those aged between 12-18 years in India
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.
Mar 23, 2022, 06:27 AM IST